Congenital adrenal hyperplasia (CAH) is a genetic disorder caused by enzyme deficiencies that disrupt hormone production in the adrenal glands, leading to imbalances in cortisol, aldosterone, and ...

Congenital adrenal hyperplasia (CAH) is a group of inherited genetic conditions that affect adrenal hormone production, causing low cortisol, low aldosterone, and excess androgen levels. Treatment may ...

Congenital adrenal hyperplasia (CAH) is a group of inherited conditions in which the adrenal glands cannot make certain hormones, most commonly due to a deficiency of the enzyme 21-hydroxylase. This ...

The clinical presentation of congenital adrenal hyperplasia (CAH) varies by age and disease severity (Figure 2-1). Patterns of adrenal steroidogenesis differ between infants and adults. The fetal ...

Cortisol insufficiency, present in all types of congenital adrenal hyperplasia (CAH), may manifest as hyperpigmentation, vomiting or a potentially life-threatening adrenal crisis, presenting with ...

Children with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency require treatment with glucocorticoids, usually at supraphysiologic doses, to address cortisol insufficiency ...

Lifelong hormone replacement therapy is the main treatment for classic congenital adrenal hyperplasia (CAH). People with simple virilizing CAH need glucocorticoid replacement, while those with salt ...

Orlando, Florida — New data add to the evidence supporting use of crinecerfont for the treatment of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, in both adults and children.

Congenital adrenal hyperplasia (CAH) is a group of inherited genetic conditions affecting the adrenal glands, causing hormone imbalances from enzyme deficiencies. These imbalances typically involve ...

Adrenal insufficiency in patients with classic 21-hydroxylase deficiency congenital adrenal hyperplasia (CAH) is treated with glucocorticoid replacement therapy. Control of adrenal-derived androgen ...